Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

Measurable residual disease (MRD) before hematopoietic cell transplantation (HCT) is an independent established prognostic factor in patients with acute myeloid leukemia (AML). Several methods exist to evaluate the presence of residual leukemia cells, but how these are used best in combination is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Orvain, Corentin, Wilson, Jacob A., Fang, Min, Sandmaier, Brenda M., Rodríguez-Arbolí, Eduardo, Wood, Brent L., Othus, Megan, Appelbaum, Frederick R., Walter, Roland B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890022/
https://www.ncbi.nlm.nih.gov/pubmed/35924583
http://dx.doi.org/10.3324/haematol.2022.281585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890022/
https://www.ncbi.nlm.nih.gov/pubmed/35924583
http://dx.doi.org/10.3324/haematol.2022.281585

Ejemplares similares